Dr Monsour said to me he believes '17 will be our year.
What's important to me is whether I believe it. Assuming V3 achieves reasonable results then given market size, health economics, lack of competition, and Peter Corr's involvement - '17 IS OUR YEAR.
Tomorrow night raise a glass to the coming year and success for Analytica Medical's shareholders.